Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIITerminatedJan 30, 2013Major Oral PeroxideStability data does not support expiration date: Stability data indicates the Carbamide Peroxide will degrade below acceptable levels within the 24-month expiration date...Axcentria Pharmaceuticals LLC · D-134-2013Class IITerminatedJan 30, 2013PredniSONE TabletsPresence of Foreign Substance: A complaint was received for black specks identified as stainless steel inclusions and cellulose with trace amounts of aluminum and...West-ward Pharmaceutical Corp. · D-133-2013Class IITerminatedJan 30, 2013Lisinopril and Hydrochlorothiazide TabletsPresence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets.West-ward Pharmaceutical Corp. · D-132-2013Class IITerminatedJan 30, 2013Propylthiouracil TabletsPresence of Foreign Substance: Uncharacteristic spots identified as steel corrosion, degraded tablet material and hydrocarbon oil with trace amounts of iron were found...West-ward Pharmaceutical Corp. · D-131-2013Class IITerminatedJan 30, 2013Lisinopril TabletsPresence of Foreign Substance: Uncharacteristic black spots identified as a food grade lubricant with trace amounts of foreign particulates and stainless steel...West-ward Pharmaceutical Corp. · D-130-2013Class IITerminatedJan 23, 2013I-C DropsLack of Assurance of Sterility: The product is being recalled because the product label does not state sterile in accordance with 21 CFR Part 200.50(a)(1), Ophthalmic...James G. Cole, Inc. · D-129-2013Class IIITerminatedJan 23, 2013CABERGOLINE TabletsImpurities/Degradation Products: This lot of product will not meet the impurity specification over shelf lifeTeva Pharmaceuticals USA, Inc. · D-128-2013Class IIITerminatedJan 23, 2013Divalproex Sodium Delayed-Release TabletsLabeling: Label Error On Declared Strength; Some bottles of product were missing the color-coded strength on the primary display panel of the label.Upsher Smith Laboratories, Inc. · D-127-2013Class IIITerminatedJan 23, 2013Perindopril Erbumine TabletsImpurities/Degradation Products: Out of Specification results found for impurity B, identified as the drug's metabolite.Boehringer Ingelheim Roxane Inc · D-126-2013Class IITerminatedJan 23, 2013Prednisone tabletsPresence of Foreign Substance(s); Perrigo has been notified of a recall by the manufacturer of this product, West-Ward Pharmaceuticals. This is a sub-recall due to...L. Perrigo Co. · D-125-2013Class IITerminatedJan 9, 2013Triamcinolone 10 mg/mL PLack of Assurance of SterilityNew England Compounding Center · D-124-2013Class IITerminatedJan 9, 2013Saline 10% and 3%Lack of Assurance of SterilityNew England Compounding Center · D-123-2013Class IITerminatedJan 9, 2013Omnipaque 240mg/mL PFLack of Assurance of SterilityNew England Compounding Center · D-122-2013Class IITerminatedJan 9, 2013Lidocaine 1% PFLack of Assurance of SterilityNew England Compounding Center · D-121-2013Class IITerminatedJan 9, 2013Lidocaine/Dextrose 5%/7.5% PFLack of Assurance of SterilityNew England Compounding Center · D-120-2013Class IITerminatedJan 9, 2013Isovue 200 mg/mL PF and 300 mg/mL PFLack of Assurance of SterilityNew England Compounding Center · D-119-2013Class IITerminatedJan 9, 2013Hyaluronidase 150 u/ml PFLack of Assurance of SterilityNew England Compounding Center · D-118-2013Class IITerminatedJan 9, 2013Glycerin 100% PFLack of Assurance of SterilityNew England Compounding Center · D-117-2013Class IITerminatedJan 9, 2013Dexamethasone Sodium Phosphate 4 mg/mL vials PFLack of Assurance of SterilityNew England Compounding Center · D-116-2013Class IITerminatedJan 9, 2013Clonidine 100 mcg/mL PFLack of Assurance of SterilityNew England Compounding Center · D-115-2013Class IITerminatedJan 9, 2013Bupivacaine 0.25% PFLack of Assurance of SterilityNew England Compounding Center · D-114-2013Class IITerminatedJan 9, 2013Betamethasone Sodium Phosphate 6 mg/mL P InjectionLack of Assurance of SterilityNew England Compounding Center · D-113-2013Class IITerminatedJan 9, 2013Betamethasone Repository 6 mg/mL PF Injection and Betamethasone Repository 6 mg/mL P InjectionLack of Assurance of SterilityNew England Compounding Center · D-112-2013Class ITerminatedJan 9, 2013Methylprednisolone Acetate 80 mg/mL InjectionNon-SterilityNew England Compounding Center · D-111-2013Class ITerminatedJan 9, 2013Methylprednisolone Acetate 40 mg/mL InjectionNon-SterilityNew England Compounding Center · D-110-2013Class ITerminatedJan 9, 2013Methylprednisolone AcetateNon-SterilityNew England Compounding Center · D-109-2013Class ITerminatedJan 9, 2013Methylprednisolone AcetateNon-SterilityNew England Compounding Center · D-108-2013Class IITerminatedJan 9, 2013SynthroidLabeling: Error on Declared Strength. Product labeled to contain 150 mcg tablets actually contained 75 mcg tablets.Abbott Laboratories · D-107-2013Class IITerminatedJan 9, 2013Epinephrine Injection USPPresence of Particulates; may contain glass particlesHospira Inc. · D-106-2013Class IITerminatedJan 2, 2013Cymevene 500 mg Powder for InfusionLack of Assurance of Sterility; container closure issues with the bulk batch.F. Hoffmann-LaRoche Ltd. · D-105-2013Class IITerminatedJan 2, 2013Levothyroxine Sodium TabletsSubpotent; 15 month stabilityAlara Pharmaceutical Co · D-104-2013Class IITerminatedJan 2, 2013LevothroidSubpotent; 9-month stability intervalLloyd Inc. of Iowa · D-103-2013Class IITerminatedJan 2, 2013Thyro-Tab 0.075 mgSubpotent; 9-month stability intervalLloyd Inc. of Iowa · D-102-2013Class IITerminatedJan 2, 2013LevothroidSubpotent; 9-month stability intervalLloyd Inc. of Iowa · D-101-2013Class IITerminatedJan 2, 2013Thyro-Tab 0.050 mgSubpotent; 9-month stability intervalLloyd Inc. of Iowa · D-100-2013Class IITerminatedDec 26, 2012Lidocaine HCl InjectionPresence of Particulate Matter: Report of a vial containing visible particulate matter embedded in the glass wall which has the potential to dislodge resulting in the...Hospira, Inc. · D-099-2013Class IIITerminatedDec 26, 2012Clean & Clear advantageSuperpotent (Single Ingredient Drug): salicylic acidJohnson & Johnson · D-098-2013Class IIITerminatedDec 26, 2012CellCeptShort Fill: some bottles contained less than 120-count per labeled claim.Genentech, Inc. · D-097-2013Class IITerminatedDec 26, 2012Nalbuphine HCl InjectionLack of Assurance of Sterility: Complains of a loose crimp applied to the fliptop vial; and a missing stopper and flip cap were received and therefore sterility cannot...Hospira, Inc. · D-096-2013Class IIITerminatedDec 26, 2012Choletec - Kit for the Preparation of Technetium Tc 99m MebrofeninPresence of Particulate Matter; potential for charcoal particulatesBracco Diagnostic Inc · D-095-2013